| BIOPHARMASPEC (UK) LIMITED |
| Registered number: 09031531 |
| Dormant Accounts |
| for the period ending: 31 December 2025 |
| Balance Sheet |
| as at 31 December 2025 |
| |
2025 |
|
2024 |
|
| |
£ |
|
£ |
| |
Assets |
| |
Unpaid called up share capital, classed as current asset |
10.00 |
|
10.00 |
| |
Cash at bank and in hand |
0.00 |
|
0.00 |
| |
Net assets |
10.00 |
|
10.00 |
| |
Issued Share Capital |
| |
10
Ordinary Shares of £
1 each |
10.00 |
|
10.00 |
|
Total Shareholder funds |
10.00 |
|
10.00 |
| Statements |
| For the period ending 31 December 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. |
| The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
| These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. |
| Approved by the board on 09 July 2026 |
| Howard Redfern MORRIS - Director |